A Follow-Up Study on 6-[18F]Fluoro-L-dopa Uptake in Early Parkinson's Disease Shows Nonlinear Progression in the Putamen

被引:60
作者
Bruck, Anna [1 ]
Aalto, Sargo [1 ,2 ]
Rauhala, Elina [1 ]
Bergman, Jorgen [1 ]
Marttila, Reijo [3 ]
Rinne, Juha O. [1 ]
机构
[1] Univ Turku, Turku PET Ctr, FIN-20521 Turku, Finland
[2] Abo Akad Univ, Dept Psychol, Turku, Finland
[3] Turku Univ Hosp, Dept Neurol, FIN-20520 Turku, Finland
关键词
Parkinson's disease; PET; 6-[8F]fluoro-L-dopa; progression; SUBSTANTIA-NIGRA; PET; DOPAMINE; FLUORODOPA; BRAIN; ROPINIROLE; F-18-DOPA;
D O I
10.1002/mds.22484
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Sixteen subjects with de novo Parkinso's disease (PD) underwent three 6-[18F]fluoro-L-dopa (Fdopa) positron emission tomography (PET) scans during a follow-up time of 5 years (mean +/- SD 5.5 +/- 0.4 years) to study the progression of striatal dopaminergic hypofunction. Throughout the study, the smallest Fdopa uptake values were found in the dorso-caudan part of the putamen contralateral to the side with dominant motor symptoms. The rate of decline in Fdopa uptake in the contralateral putamen was faster in the begining of the disease and slowed down as the disease progressed. The annual decline in Fdopa influx constant (ki, unit x 10(-3) min(-1)) was on average 0.5 during the first 2 years and 0.2 during the subsequent 3 years (P = 0.002) in the contralateral putamen. IN caudate, the rate of decline in Fdopa values was slower than in the putamen and did not change significantly during the follow-up time, annual decline in the contralateral caudate being 0.1 between base-line and 2 years and 0.3 between 2 and 5 years (P = 0.4). These results suggest that progression of putaminal dopaminergic hypofunction in PD follows a nonlinear pattern at least in the contralateral side being faster in the beginning of the disease. (C) 2009 Movement Disorder Society
引用
收藏
页码:1009 / 1015
页数:7
相关论文
共 25 条
[1]  
Bergman J., 1994, Journal of Labelled Compounds and Radiopharmaceuticals, V35, P476
[2]  
BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
[3]   Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease [J].
Brück, A ;
Aalto, S ;
Nurmi, E ;
Bergman, J ;
Rinne, JO .
NEUROBIOLOGY OF AGING, 2005, 26 (06) :891-898
[4]   Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease:: A two-year follow-up study [J].
Bruck, Anna ;
Aalto, Sargo ;
Nurmi, Elina ;
Vahlberg, Tero ;
Bergman, Jogen ;
Rinne, Juha O. .
MOVEMENT DISORDERS, 2006, 21 (07) :958-963
[5]   The substantia nigra of the human brain - II. Patterns of loss of dopamine-containing neurons in Parkinson's disease [J].
Damier, P ;
Hirsch, EC ;
Agid, Y ;
Graybiel, AM .
BRAIN, 1999, 122 :1437-1448
[6]   AGING AND PARKINSONS-DISEASE - SUBSTANTIA-NIGRA REGIONAL SELECTIVITY [J].
FEARNLEY, JM ;
LEES, AJ .
BRAIN, 1991, 114 :2283-2301
[7]   Clinical features at first visit and rapid disease progression in Parkinson's disease [J].
Ferguson, Leslie W. ;
Rajput, Michele L. ;
Muhajarine, Nazeem ;
Shah, Syed M. ;
Rajput, Alexander .
PARKINSONISM & RELATED DISORDERS, 2008, 14 (05) :431-435
[8]   Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease [J].
Forsback, S ;
Niemi, R ;
Marjamäki, P ;
Eskola, O ;
Bergman, J ;
Grönroos, T ;
Haaparanta, M ;
Haapalinna, A ;
Rinne, J ;
Solin, O .
SYNAPSE, 2004, 51 (02) :119-127
[9]  
Friston K., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402
[10]   Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity [J].
Hilker, R ;
Schweitzer, K ;
Coburger, S ;
Ghaemi, M ;
Weisenbach, S ;
Jacobs, AH ;
Rudolf, J ;
Herholz, K ;
Heiss, WD .
ARCHIVES OF NEUROLOGY, 2005, 62 (03) :378-382